Posted on 3/16/21
COVID Roundup: Va. Deaths Surpass 10,000; 21% of Population Vaccinated
Virginia exceeded 10,000 coronavirus-related deaths as of March 15, one year and one day after the first COVID-19 death was recorded in the state.Also, 21% of . . .
Posted on 3/15/21
2021’s States with the Most & Least Medicaid Coverage – WalletHub Study
With the Biden administration reversing work requirements for Medicaid coverage and the COVID-19 pandemic highlighting the importance of good healthcare, the personal finance website WalletHub today . . .
Posted on 3/15/21
Virginians Ages 65+ Have Mostly Gotten COVID Shots
With more than 1.6 million Virginians having received COVID-19 vaccinations, the number of people age 65 and older seeking COVID-19 shots is beginning to slow down, . . .
Posted on 3/15/21
Could Novavax Win U.S. Authorization for Its COVID Vaccine by May?
Three COVID-19 vaccines are already on the market in the U.S. Another could be on the way. Novavax(NASDAQ:NVAX) CEO Stanley Erck thinks his company's vaccine just . . .
Posted on 3/15/21
The Better Stock for 2021: Moderna or Novavax?
So, we want to find out what the smartest investors are saying about a stock. What's one of the best ways of doing that? By playing . . .
Posted on 3/12/21
Health Wagon Receives COVID-19 Vaccine Doses After Wait
A little more than a month after The Health Wagon’s director went on national television and said the Wise County-based free clinic system hadn’t received COVID-19 . . .
Posted on 3/12/21
What Are Novavax's Long-Term Prospects?
Last year, Novavax (NASDAQ:NVAX) was one of the strongest stocks in the entire market. The micro cap ran up from $4 a share in January all . . .
Posted on 3/12/21
Novavax Coronavirus Vaccine Candidate Shows 96% Efficacy With Original Strain, 86% Against U.K. Variant
Will Novavax's (NASDAQ:NVAX) NVX-CoV2373 be the next coronavirus vaccine to win major regulatory approval? Its prospects look good after the company's release of two sets of . . .
Posted on 3/11/21
3 Reasons to Buy Novavax Stock After Its Huge Pullback
Novavax (NASDAQ:NVAX) got off to a fantastic start this year. By early February, the stock had soared more than 180% year to date. But it hasn't . . .
Posted on 3/10/21
Novavax: Uncertain COVID-19 Vaccine Approval Triggers Violent Sell-Off
Summary NVAX's quarterly revenue rose over 75% Q/Q. COVID-19 supply spurred growth.Regulatory approval for a vaccine may not happen until Q2. It could take a few . . .
Posted on 3/10/21
Could Novavax Be a Millionaire-Maker Stock?
If you invested $10,000 in Novavax (NASDAQ:NVAX) last March, that principal would be worth nearly $133,000 just one year later. But over the past month or . . .
Posted on 3/10/21
Ashby Ponds Vaccinates 98% of Residents Against COVID-19
Celebrates milestone with fireworks show to express appreciation to residents, employees A resident of Ashby Ponds enjoys a special fireworks show that the Erickson Living-managed community held . . .
Posted on 3/9/21
Advarra Acquires Bio-Optronics
Advarra, the market leader in regulatory review solutions, research quality and compliance consulting services and clinical site-centric technologies, today announced that it has acquired Bio-Optronics, maker . . .
Posted on 3/9/21
COVID Roundup: 1 Year Into Pandemic, Va. Makes Headway with Vaccinations
A year after the first COVID-19 cases in Virginia were recorded, the state is making significant headway in vaccinating residents. As of Monday, March 8, 1.49 . . .
Posted on 3/8/21
Novavax Is Preselling Its Coronavirus Vaccine, but at What Price?
Novavax (NASDAQ:NVAX) reached an agreement to sell 1.1 million doses of its coronavirus vaccine to COVAX, an organization led by the Coalition of Epidemic Preparedness Innovations, . . .
Posted on 3/7/21
David Nevins Interviews Dr. Matthew Frieman, Associate Professor, University of Maryland School of Medicine
Dr. Frieman’s overall research goal is to create therapeutic interventions for viruses of public health concern by developing
Posted on 3/5/21
These 2 Elements in Novavax's Earnings Report Could Mean Billions for the Biotech
Novavax (NASDAQ:NVAX) reported a widening loss in the most recent quarter. And, as a clinical-stage biotech, the company doesn't generate product revenue. But I'm not surprised . . .
Posted on 3/5/21
Luminis Health is Opening its Doors to Visitors Again
Luminis Health Anne Arundel Medical Center (LHAAMC) and Luminis Health Doctors Community Medical Center (LHDCMC) have opened their doors to limited patient visitation. The guidelines allow . . .
Posted on 3/4/21
Safest States During COVID-19 – Updated WalletHub Study
With only 7.9% of the population fully vaccinated against COVID-19 as of March 2, and vaccination being an essential component for full reopening of the economy, . . .
Posted on 3/4/21
90K Johnson & Johnson Shots Arriving in Va. This Week
More than 90,000 Johnson & Johnson COVID-19 vaccine doses are arriving in Virginia now through Thursday, the state vaccine coordinator said Wednesday afternoon.According to Dr. Danny . . .
Posted on 3/4/21
Colfax To Separate Into Two Independent Public Companies
Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its intention to separate its fabrication technology and specialty medical
Posted on 3/4/21
Novavax's COVID Vaccine Trial: Are There Any Yellow Flags So Far?
Novavax(NASDAQ:NVAX) has completed enrollment in its late-stage study of COVID-19 vaccine NVX-CoV2373 that's being conducted in the U.S. and Mexico. The biotech recently released some details . . .
Posted on 3/4/21
Owens & Minor Prices $500M of Senior Notes
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) announced today the pricing of its private offering of $500 million aggregate principal amount of its 4.500% senior . . .
Posted on 3/3/21
2021’s Most Overweight and Obese Cities in the U.S. – WalletHub Study
With March being National Nutrition Month and obesity possibly tripling the risk of hospitalization due to COVID-19, the personal-finance website WalletHub today released its report on . . .
Posted on 3/3/21
What Really Mattered With Novavax's Q4 Update
Long-time investors know that the market is always forward-looking. What's potentially on the way is always more important than what's in the past. Novavax (NASDAQ:NVAX) just . . .
Washington DC
